PIPELINE COMPANIES

CYTEA|BIO is a preclinical-stage biotechnology company focusing on allogeneic cellular immunotherapies. The company has developed and patented the Pin™ platform, a versatile and modular cell therapy platform enabling the combination of unmodified immune effector cells and targeting ligands. CYTEA|BIO is the first pipeline company of MedXCell.

PIPELINE PROJECTS (IN-HOUSE)